Frontiers in pharmacology

the chinese journal of physiology

phytomedicine : international journal of phytotherapy and phytopharmacology

PeerJ

drug metabolism and pharmacokinetics

Environmental science & technology

Frontiers in physiology

Journal of veterinary internal medicine

Molecular and cellular biochemistry

[1] Adenine decreases hypertrophic effects through interleukin-18 receptor.

[2] The heart of a hibernator: EGFR and MAPK signaling in cardiac muscle during the hibernation of thirteen-lined ground squirrels, .

[3] Transcriptomic Validation of the Protective Effects of Aqueous Bark Extract of (Roxb.) on Isoproterenol-Induced Cardiac Hypertrophy in Rats.

[4] In vitro metabolic stability and biotransformation of isosteviol in human and rat liver fractions.

[5] Mechanistic insights to the cardioprotective effect of blueberry nutraceutical extract in isoprenaline-induced cardiac hypertrophy.

[6] Refining the Mouse Subtotal Nephrectomy in Male 129S2/SV Mice for Consistent Modeling of Progressive Kidney Disease With Renal Inflammation and Cardiac Dysfunction.

[7] Abiotic Degradation of Chlorinated Solvents by Clay Minerals and Fe(II): Evidence for Reactive Mineral Intermediates.

[8] Associations among echocardiography, cardiac biomarkers, insulin metabolism, morphology, and inflammation in cats with asymptomatic hypertrophic cardiomyopathy.

[9] diabetic cardiomyopathy: impact of biological sex on disease development and molecular signatures

[10] corrigendum: fvb/nj mice are a useful model for examining cardiac adaptations to treadmill exercise

[11] severe renal vascular hypertension caused by upper left branch renal artery stenosis complicated with multiple thrombosis and cardiac hypertrophy

[12] roles of pde1 in pathological cardiac remodeling and dysfunction

[13] arctiin protects against cardiac hypertrophy through inhibiting mapks and akt signaling pathways

[14] rapamycin inhibits cardiac hypertrophy by promoting autophagy via the mek/erk/beclin-1 pathway

[15] global microrna profiles and signaling pathways in the development of cardiac hypertrophy

[16] acute and chronic effects of protein kinase-d signaling on cardiac energy metabolism

[17] exercise training attenuates right ventricular remodeling in rats with pulmonary arterial stenosis

[18] Linking type 2 diabetes mellitus, cardiac hypertrophy and depression in a diurnal animal model

[19] Transcriptomic Validation of the Protective Effects of Aqueous Bark Extract of (Roxb.) on Isoproterenol-Induced Cardiac Hypertrophy in Rats.

[20] Mechanistic insights to the cardioprotective effect of blueberry nutraceutical extract in isoprenaline-induced cardiac hypertrophy.

[21] N-Acetyl Cysteine Inhibits Endothelin-1-Induced ROS Dependent Cardiac Hypertrophy through Superoxide Dismutase Regulation

[22] [Unusual abnormality of the myocardial structure in so-called idiopathic cardiac hypertrophy]

[23] [Unusual abnormality of the myocardial structure in so-called idiopathic cardiac hypertrophy].

[24] protective role for lpa3 in cardiac hypertrophy induced by myocardial infarction but not by isoproterenol

[25] bezafibrate attenuates pressure overload-induced cardiac hypertrophy and fibrosis

[26] diallyl disulfide ameliorates isoproterenol induced cardiac hypertrophy activating mitochondrial biogenesis via enos-nrf2-tfam pathway in rats

[27] severe renal vascular hypertension caused by upper left branch renal artery stenosis complicated with multiple thrombosis and cardiac hypertrophy

[28] pioglitazone protected against cardiac hypertrophy via inhibiting akt/gsk3β and mapk signaling pathways

[29] arctiin protects against cardiac hypertrophy through inhibiting mapks and akt signaling pathways

[30] effects of wenxin keli on cardiac hypertrophy and arrhythmia via regulation of the calcium/calmodulin dependent kinase ii signaling pathway

[31] rapamycin inhibits cardiac hypertrophy by promoting autophagy via the mek/erk/beclin-1 pathway

[32] genetic background influences adaptation to cardiac hypertrophy and ca2+ handling gene expression

[33] global microrna profiles and signaling pathways in the development of cardiac hypertrophy

[34] garlic oil alleviates mapks- and il-6-mediated diabetes-related cardiac hypertrophy in stz-induced dm rats

[35] Mog1 knockout causes cardiac hypertrophy and heart failure by downregulating tbx5-cryab-hspb2 signalling in zebrafish

[36] Inhibition of Uncoupling Protein 2 Attenuates Cardiac Hypertrophy Induced by Transverse Aortic Constriction in Mice